AG7088

A rhinovirus 3C protease inhibitor (anti-viral) intended for use on the common cold. It made it as far as Phase II trials before Agouron stopped development.

References in periodicals archive ?

In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease.

Potential use of antiviral agents in polio eradication

They believe the virus could be treated by a modified version of an experimental common cold drug called AG7088.

Cold drug may combat Sars; UK/INTERNATIONAL

Agouron's rhinovirus 3C protease inhibitor AG7088 is in human clinical trials for the proposed treatment of the common cold.

Good Health Is Essential To The Good Life

The American drug company Agouron Pharmaceuticals have come closest with a drug called AG7088 that stops the cold virus reproducing.

Your health: Focus on colds and flu

Currently in Phase II studies, AG7088 could enter large scale Phase III clinical studies later this year and possibly lead to an NDA by the end of 2001.

Warner-Lambert Reaffirms 30 Percent EPS Growth in 1999 and Expects to Achieve 20 Percent EPS Growth in 2000

Full browser ?

CITE

Site: Follow: Share:

Open / Close